CA - Crescita Therapeutics GAAP EPS of -C$0.01 revenue of C$4.6M May, 11 2023 01:50 PM CA Inc. 2023-05-11 13:50:00 ET Crescita Therapeutics press release ( OTCPK:CRRTF ): Q1 GAAP EPS of -C$0.01. Revenue of C$4.6M (-7.1% Y/Y). For further details see: Crescita Therapeutics GAAP EPS of -C$0.01, revenue of C$4.6M